Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 25% ± 8% | |
| glutamatergic neuron | 3 studies | 30% ± 13% |
Insufficient scRNA-seq data for expression of ELFN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 3326.21 | 2515 / 2642 | 87% | 32.63 | 614 / 705 |
| prostate | 48% | 309.38 | 117 / 245 | 83% | 8.64 | 415 / 502 |
| kidney | 33% | 161.22 | 29 / 89 | 47% | 4.00 | 421 / 901 |
| lung | 38% | 171.88 | 218 / 578 | 34% | 2.78 | 398 / 1155 |
| pancreas | 16% | 66.85 | 54 / 328 | 50% | 2.87 | 89 / 178 |
| liver | 7% | 36.36 | 15 / 226 | 40% | 2.33 | 161 / 406 |
| adrenal gland | 6% | 22.05 | 15 / 258 | 32% | 2.07 | 73 / 230 |
| skin | 27% | 206.41 | 483 / 1809 | 7% | 0.54 | 31 / 472 |
| eye | 0% | 0 | 0 / 0 | 33% | 2.42 | 26 / 80 |
| thymus | 0% | 0.33 | 1 / 653 | 31% | 2.41 | 187 / 605 |
| esophagus | 1% | 2.18 | 8 / 1445 | 16% | 1.06 | 30 / 183 |
| stomach | 0% | 0.58 | 1 / 359 | 15% | 0.93 | 43 / 286 |
| intestine | 1% | 1.67 | 6 / 966 | 12% | 0.65 | 62 / 527 |
| uterus | 1% | 2.19 | 1 / 170 | 12% | 0.76 | 54 / 459 |
| bladder | 0% | 0 | 0 / 21 | 9% | 0.57 | 47 / 504 |
| breast | 1% | 4.22 | 6 / 459 | 7% | 0.48 | 76 / 1118 |
| ovary | 0% | 0 | 0 / 180 | 7% | 0.31 | 30 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.14 | 1 / 45 |
| adipose | 1% | 3.10 | 12 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 0% | 1.20 | 1 / 241 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.52 | 2 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.56 | 3 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.11 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0016020 | Cellular component | membrane |
| GO_0005615 | Cellular component | extracellular space |
| GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
| Gene name | ELFN2 |
| Protein name | Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62) |
| Synonyms | KIAA1904 LRRC62 PPP1R29 |
| Description | FUNCTION: Inhibits phosphatase activity of protein phosphatase 1 (PP1) complexes. . |
| Accessions | Q5R3F8 ENST00000402918.7 |